New hope for neurotrophin targeting in osteoarthritis pain? - PubMed
6 hours ago
- #neurotrophin
- #conflict of interest
- #osteoarthritis
- There is new hope for targeting neurotrophins in osteoarthritis pain.
- The author has received research funding and consultancy fees from multiple pharmaceutical companies, including GSK, Zoetis, Novartis, UCB, Fidia, Biosplice, Pfizer, and Galapagos.
- Conflicts of interest are disclosed, with specific mentions of involvement in STEpUP OA and advisory roles.